ProfileGDS5822 / ILMN_2542289
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 14% 35% 9% 39% 45% 20% 31% 12% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 111.214
GSM1276600PDAC Late Ablation Control 218.635
GSM1276601PDAC Late Ablation Control 3
GSM1276602PDAC Late Ablation 18.49
GSM1276603PDAC Late Ablation 218.339
GSM1276604PDAC Late Ablation 321.545
GSM1303940PDAC Late Ablation_anti-CTLA4 112.820
GSM1303941PDAC Late Ablation_anti-CTLA4 215.331
GSM1303942PDAC Late Ablation_anti-CTLA4 37.412